VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 8 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $275,000 | -44.8% | 3,150 | -10.9% | 0.00% | -95.5% |
| Q1 2018 | $498,000 | -53.8% | 3,535 | -23.2% | 0.02% | -52.2% |
| Q4 2017 | $1,077,000 | -33.4% | 4,602 | -14.7% | 0.05% | -30.3% |
| Q3 2017 | $1,618,000 | +26.6% | 5,397 | -20.9% | 0.07% | +17.9% |
| Q2 2017 | $1,278,000 | -50.2% | 6,819 | -11.9% | 0.06% | -49.5% |
| Q1 2017 | $2,566,000 | -41.7% | 7,739 | +4.7% | 0.11% | -57.8% |
| Q4 2016 | $4,403,000 | -1.1% | 7,395 | -1.1% | 0.26% | -12.9% |
| Q3 2016 | $4,452,000 | -32.0% | 7,479 | -9.3% | 0.30% | -31.1% |
| Q2 2016 | $6,549,000 | -63.4% | 8,247 | -28.8% | 0.44% | -69.3% |
| Q1 2016 | $17,876,000 | +109.3% | 11,589 | +106.2% | 1.42% | +113.0% |
| Q4 2015 | $8,541,000 | +49.3% | 5,621 | +113.6% | 0.67% | +59.7% |
| Q3 2015 | $5,719,000 | +1687.2% | 2,631 | +86.5% | 0.42% | +1451.9% |
| Q2 2015 | $320,000 | +30.6% | 1,411 | +36.5% | 0.03% | -3.6% |
| Q1 2015 | $245,000 | -11.6% | 1,034 | +4.3% | 0.03% | -17.6% |
| Q4 2014 | $277,000 | – | 991 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|